knowledge -WSS

knowledge

author：fashion 2025-09-27 12:34:50 - browse：792

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology

WSS

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Covid isolation guidance eased by the CDC

Biotech companies concerned about China biosecurity crackdown

Flu vaccine offering decent levels of protection this winter, new data show

AstraZeneca loses challenge to Medicare drug price negotiation

Biotech companies concerned about China biosecurity crackdown

focus

knowledge

Wikipedia

Affirmative action in medical school literally saved lives

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

The high cost of giving birth even with insurance

Clinical trials giant ICON acquires HumanFirst

As demand for Covid shots wanes, Moderna seeks its next success

Dana Farber says 6 studies to be retracted and 31 corrected

Guidelines to prevent youth baseball injuries need more muscle

Printout prescription drug information shouldn’t go digital

After affirmative action ruling, medical educators look to 'holistic review'

Medicare bonuses could stop drug shortages under Senate plan

focus

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Pfizer highlights cancer drugs it thinks could reignite investor interest

HPV vaccine, cervical cancer study delivers historic results

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

RaDonda Vaught to speak at CommonSpirit event on patient safety

House looks to weaken Medicare negotiation

hotspot

knowledge

focus

focus